Maverick Trader Reveals 97% Accurate System

This man's simple strategy makes money in any market...With a 97% accuracy at hitting winners over the past 8 years!

REGN
Regeneron Pharmaceuticals, Inc
NASDAQ
602.64
Open 598.33 Prev Close 599.76
High 602.79 Low 585.78
Volume 964,394 Volume (Avg) 999
52 Week High 1,209.65 52 Week Low 525.99
Market Cap 65.5B PE Ratio 15.74

Shares Stats

Shares Outstanding107,800,000
Shares Float104,850,000
Shares Short2,600,000
Insider Holdings158%
Institution Holdings91.84%

About Regeneron Pharmaceuticals, Inc

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection for heterozygous familial hypercholesterolemia (HoFH) or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; Evkeeza for treatment of HoFH; Ordspono for Follicular lymphoma and Diffuse large B-cell lymphoma; and Veopoz for CD55-deficient protein-losing enteropathy. Further, it develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration with Mammoth Biosciences, Inc. to research, develop and commercialize in vivo CRISPR-based gene editing therapies for multiple tissues and cell types; and with Sonoma Biotherapeutics, Inc. to discover, develop, and commercialize engineered regulatory T cell therapies. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.

General

NameRegeneron Pharmaceuticals, Inc
TickerREGN
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CurrencyUSD
CountryUSA
Fiscal Year EndDecember
Full Time Employees15,106

Highlights

Analyst Target857.67
Market Cap65,549,200,000
PE Ratio15.74
PEG Ratio0.96
EBITDA4,627,999,744

Financials

Curr Year EPS Estimate39.38
Next Quarter EPS Estimate10.25
Profit Margin31.07%
Operating Margin28.97
Return on Assets0.07
Return on Equity0.16
Revenue14.2B
Earnings Per Share38.33
Revenue Per Share131.62
Gross Profit7,099,500,032
Quarterly Revenue Growth0.10

Valuation

Trailing PE15.72
Forward PE14.31
Price/Sales (Trailing 12 Mt.)4.62
Price/Book (Most Recent Quarter)2.24

Dividend

Regeneron Pharmaceuticals, Inc pays out a dividend of $2.83 per share, with a dividend yield of 0.47%.

REGN's last dividend payment was made to shareholders on March 20, 2025.

They pay out 0.00% of their earnings out as a dividend.

Recent Dividends

Mar 20, 2025$0.88
Most Popular

Yale Classmates Urge Bessent To Reconsider Trump White House Role — Treasury Secretary Calls It an 'Honor'

A group of Yale University alumni publicly appealed to Treasury Secretary Bessent, urging him to reevaluate his position within the Trump administration.

Deadly Blast at Iranian Port Tied to Missile Fuel Shipment: 5 Dead, More Than 700 Injured

A colossal explosion Saturday at a port in southern Iran, associated with a missile propellant shipment, claimed at least five lives and injured more than 700 people.

Elon Musk Drops Stunning Bombshell? - Ad

Behind closed doors, Musk revealed a game-changing breakthrough technology that could shake the tech world & crush major companies. Why is no one talking about it? Luckily, we had a man on the inside - watch now to see the details & how to profit!

Top "60 Minutes" producer quits, saying he can no longer run the show as he has

NEW YORK (AP) — The top producer at “60 Minutes” said Tuesday that he is quitting the show, saying that it has become clear that he would no longer be able to run it as he has in the past.

IRS whistleblower on Hunter Biden is out as acting commissioner just days after getting the job

WASHINGTON (AP) — Just days after to acting IRS commissioner, the whistleblower who testified publicly about investigations into Hunter Biden’s taxes is out of the job, according to three people familiar with the decision.

A "Backdoor" Way to Claim a Stake in Elon's Optimus Before Its Launch - Ad

In 2017, Elon Musk went on record to say his Optimus could be "capable of doing anything". One Silicon Valley insider has identified a little-known "backdoor" way to invest in Optimus before its launch. This under-the-radar play could deliver astronomical returns - and you can get started with as little as $100.

Why Barrick Gold Stock Is Trading Lower

Barrick Gold Corp (NYSE:GOLD) shares are trading lower by 4.5% to $19.08 during Wednesday’s session.

New Study: 50 Stocks Will Crash While 7 MAGA Stocks Will Soar - Ad

If you own any of these stocks -- directly or through mutual funds -- I want to encourage you to sell them before April 30th. I've compiled all 50 companies in my "MAGA Blacklist" report. Your retirement could depend on seeing this list.

Gentex Q1 Impacted By Tariff Uncertainty, Suspends Mirror Production For Chinese Market

Gentex shares fall as Q1 results reflect tariff pressures, prompting a halt in China-bound mirror production and a lowered 2025 sales outlook.

Trump Exec Order to Help Restore Wealth for American Citizens? - Ad

Thanks to President Trump's Executive Order 14179, a brief "AI Wealth Window" is opening now. Genius investor James Altucher has released 3 AI wealth-building strategies to take advantage of Trump's genius Executive Order 14179. James believes you could see $10,000 grow to $1 MILLION or more over the next few years.

Meet the Key Five People Who Are Shaping Trump's Economic Agenda

In the midst of a broad tariff agenda that has caused turmoil in financial markets, President Trump is relying on a diverse group of economic advisers to guide his policies.

Despite a court order, White House bars AP from Oval Office event

Despite a court order, a reporter and photographer from The Associated Press were barred from an Oval Office news conference on Monday with President Donald Trump and his counterpart from El Salvador, Nayib Bukele.

No.1 Opportunity for 2025 [Take Action Now!] - Ad

Starlink's potential IPO Could Be the Biggest in History--Silicon Valley insider James Altucher has uncovered a way to profit BEFORE the IPO--with as little as $50. Musk's $180B giant is set to launch--will you miss out? Claim your spot before it's too late.

US Treasury secretary says trade war with China is not 'sustainable'

WASHINGTON (AP) — U.S. Treasury Secretary said in a Tuesday speech that the ongoing against China is unsustainable and expects a "de-escalation" in the trade war between the world's two largest economies.

Trump nominee withdraws after her criticism of the Jan. 6 Capitol attack surfaces

BILLINGS, Mont. (AP) — President Donald Trump's nominee to oversee an agency that manages has withdrawn her nomination following revelations that she criticized the Republican president in 2021 for inciting the Jan. 6 attack on the U.S. Capitol.

The Most Important "AI Stock" You've Never Heard Of - Ad

The AI revolution is moving faster than anyone expected. But what no one is talking about is the one company AI simply can't exist without. It may be the single most important AI investment, yet most people don't even know its name. For now. The moment Wall Street catches on, this $20 stock could explode.

Beyoncé Partnership, Strong Sales And Low China Exposure - Analyst Upgrades Levi Strauss To Buy

Levi Strauss & Co. (NYSE:LEVI) gets a bullish nod from BofA, highlighting its global brand strength, solid first-quarter results, and robust wholesale recovery. With low leverage and limited China risk, LEVI's diversified growth strategy fuel optimism.

Oregon agency won’t say if hackers stole data in cyberattack

PORTLAND, Ore. (AP) — Oregon's environmental agency won't say if a group of hackers stole data in a cyberattack that was first announced earlier this month.

Elon's Greatest Invention... Hidden in South Memphis? - Ad

Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believes will be Elon's greatest invention ever... Yes, even bigger than Tesla or SpaceX.

Meet The New Income Machines: Simplify Debuts SBAR And XV

Simplify Asset Management launches two innovative ETFs designed to provide structured, high-yielding income with well-defined downside risk in today's challenging investing environment.

Palantir Goes Bullish After NATO's AI Buy: Is This The Future Of War, Wall Street?

Palantir's stock jumps 9% after NATO acquires its AI-enabled system, showing its dominance in data and potential for growth.

Nvidia Is About to Shock the World: July 23rd - Ad

Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%, is warning everyone to... Mark this date on your calendar: July 23rd! That's when Nvidia could help send shares of this Elon Musk supplier skyrocketing higher.

Elon Musk's Tesla Reportedly Manipulating Odometers To Dodge Warranty Repairs

Tesla is facing lawsuit over odometer manipulation. Plaintiff claims premature warranty expiration, seeking damages for California Tesla drivers.

Decoding Jeff Bezos' Unique Amazon Interview Question: A Key To Hiring Success?

Jeff Bezos, during his time at Amazon, reportedly had an unconventional method of interviewing prospective employees, always posing them one unusual question: "Are you a lucky person?"

You Can Take a Stake in Elon's xAI Before May 1st... - Ad

Elon Musk's private AI firm xAI may have just leapfrogged ChatGPT and Google's Gemini--building what experts call the future of AI. For the first time, you can take a stake starting at $500.

World Economic Forum board backs launch of independent probe into founder Klaus Schwab

GENEVA (AP) — The World Economic Forum, which runs an annual gathering of elites in Davos, Switzerland, says its board has given its unanimous support for an independent investigation into allegations of misconduct by founder Klaus Schwab.

What's Going On With Marin Software (MRIN) Stock?

Marin Software shares are trading lower by 23.7% during Wednesday's session. The company announced it received a notice from Nasdaq on April 16.

Putting Your Name on This List Could Hand You $1,270 on Friday - Ad

URGENT: On Tuesday, a simple set of instructions will be sent out to an elite group of investors. The folks in this group will have the opportunity to place a 10-minute trade that could double their money by Friday. Consider this your invitation to join them. The next trade is just days away.

Maryland Senator Grabs National Spotlight With El Salvador Meeting With Deportee

Sen. Chris Van Hollen (D-Md.), a longtime but mostly low-profile legislator, has surged into the national spotlight following a trip to El Salvador to meet with Kilmar Abrego Garcia.

Nintendo Switch 2 preorders see 'overwhelming' demand, frustrations for hopeful buyers

NEW YORK (AP) — U.S. preorders for the kicked off shortly after the clock struck midnight Thursday. But chaos soon ensued amid high demand.

Brace Yourself for Jeff Bezos' "Amazon Helios" - Ad

Amazon delivers 20 million packages a day... powers some of the most popular websites... delivers medication to half of the U.S. population... and even produces award-winning films and TV shows. But a Wall Street legend -- twice featured on 60 Minutes -- predicts that "Amazon Helios" will be bigger than all of those... COMBINED.

Greenback On The Brink: The Dollar ETFs Everyone's Watching

ETFs tracking US dollar gaining attention as currency faces pressure amid trade tensions and weak economy.

FDA Approves Dexcom's 15-Day Wearable Glucose Management System. Company Plans US Launch

Dexcom G7 15-Day CGM approved by FDA for adults with diabetes; U.S. launch set for late 2025 with extended wear and advanced tracking features.

World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" - Ad

Sam Altman, Bill Gates, and Mark Zuckerberg are all investing vast sums of money into a radical technology. According to Bloomberg, this could become 10 times bigger than AI, quantum computing, electric vehicles, cryptocurrencies, and robotics combined. And one stock is at the center of it all.

As Trump considers auto tariffs pause, parts exemptions could be key for US industry

DETROIT (AP) — President Donald Trump hinted that he might temporarily relieve the auto industry from “permanent” on the business. The president didn't specify how long the potential pause would be or what it would entail, but is awaiting how rules might change on 25% tariffs based on U.S. parts, if duties remain on assembled vehicles.

Dan Ives Cuts Tesla Target To $315, Slashes Apple By 23% Amid Tariff Fallout, Warns Elon Musk-Led EV Maker Faces 'Darker Days' Ahead

Wedbush Securities analyst Dan Ives has lowered his Tesla Inc. price target to $315 from $550 while maintaining an "outperform" rating, citing growing concerns about the electric vehicle maker's brand perception and softening demand.

Maverick Trader Reveals 97% Accurate System - Ad

This man's simple strategy makes money in any market...With a 97% accuracy at hitting winners over the past 8 years!

Trump Says He May Deserve A Nobel Peace Prize For This Reason

U.S. President Donald Trump hinted that his contribution to the Abraham Accords could potentially make him a worthy contender for the Nobel Peace Prize.

Most Recent

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright trendadvisor.net
Privacy Policy | Terms of Service